The clinical case for proton beam therapy

Robert L. Foote; Scott L. Stafford; Ivy A. Petersen; Jose S. Pulido; Michelle J. Clarke; Steven E. Schild; Yolanda I. Garces; Kenneth R. Olivier; Robert C. Miller; Michael G. Haddock; Elizabeth Yan; Nadia N. Laack; Carola A.S. Arndt; Steven J. Buskirk; Vickie L. Miller; Christopher R. Brent; Jon J. Kruse; Gary A. Ezzell; Michael G. Herman; Leonard L. Gunderson; Charles Erlichman; Robert B. Diasio

doi:10.1186/1748-717X-7-174

The clinical case for proton beam therapy

Robert L. Foote, Scott L. Stafford, Ivy A. Petersen, Jose S. Pulido, Michelle J. Clarke, Steven E. Schild, Yolanda I. Garces, Kenneth R. Olivier, Robert C. Miller, Michael G. Haddock, Elizabeth Yan, Nadia N. Laack, Carola A.S. Arndt, Steven J. Buskirk, Vickie L. Miller, Christopher R. Brent, Jon J. Kruse, Gary A. Ezzell, Michael G. Herman, Leonard L. GundersonCharles Erlichman, Robert B. Diasio

Research output: Contribution to journal › Review article › peer-review

34 Scopus citations

Abstract

Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tumor control and survival through dose escalation. It also has potential for reducing harm to normal organs through dose reduction. However, proton beam therapy is more costly than conventional x-ray therapy. This increased cost may be offset by improved function, improved quality of life, and reduced costs related to treating the late effects of therapy. Clinical research opportunities are abundant to determine which patients will gain the most benefit from proton beam therapy. We review the clinical case for proton beam therapy.Proton beam therapy is a technically advanced and promising form of radiation therapy.

Original language	English (US)
Article number	174
Journal	Radiation Oncology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/1748-717X-7-174
State	Published - Oct 22 2012

Keywords

Clinical review
Neoplasms
Proton beam therapy
X-ray therapy

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1186/1748-717X-7-174

Cite this

Foote, R. L., Stafford, S. L., Petersen, I. A., Pulido, J. S., Clarke, M. J., Schild, S. E., Garces, Y. I., Olivier, K. R., Miller, R. C., Haddock, M. G., Yan, E., Laack, N. N., Arndt, C. A. S., Buskirk, S. J., Miller, V. L., Brent, C. R., Kruse, J. J., Ezzell, G. A., Herman, M. G., ... Diasio, R. B. (2012). The clinical case for proton beam therapy. Radiation Oncology, 7(1), Article 174. https://doi.org/10.1186/1748-717X-7-174

Foote, RL, Stafford, SL, Petersen, IA, Pulido, JS, Clarke, MJ, Schild, SE, Garces, YI, Olivier, KR, Miller, RC, Haddock, MG, Yan, E, Laack, NN , Arndt, CAS, Buskirk, SJ, Miller, VL, Brent, CR, Kruse, JJ, Ezzell, GA, Herman, MG, Gunderson, LL, Erlichman, C & Diasio, RB 2012, 'The clinical case for proton beam therapy', Radiation Oncology, vol. 7, no. 1, 174. https://doi.org/10.1186/1748-717X-7-174

@article{75a586e38c2c4b1d89cbe695cc46419b,

title = "The clinical case for proton beam therapy",

abstract = "Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tumor control and survival through dose escalation. It also has potential for reducing harm to normal organs through dose reduction. However, proton beam therapy is more costly than conventional x-ray therapy. This increased cost may be offset by improved function, improved quality of life, and reduced costs related to treating the late effects of therapy. Clinical research opportunities are abundant to determine which patients will gain the most benefit from proton beam therapy. We review the clinical case for proton beam therapy.Proton beam therapy is a technically advanced and promising form of radiation therapy.",

keywords = "Clinical review, Neoplasms, Proton beam therapy, X-ray therapy",

author = "Foote, {Robert L.} and Stafford, {Scott L.} and Petersen, {Ivy A.} and Pulido, {Jose S.} and Clarke, {Michelle J.} and Schild, {Steven E.} and Garces, {Yolanda I.} and Olivier, {Kenneth R.} and Miller, {Robert C.} and Haddock, {Michael G.} and Elizabeth Yan and Laack, {Nadia N.} and Arndt, {Carola A.S.} and Buskirk, {Steven J.} and Miller, {Vickie L.} and Brent, {Christopher R.} and Kruse, {Jon J.} and Ezzell, {Gary A.} and Herman, {Michael G.} and Gunderson, {Leonard L.} and Charles Erlichman and Diasio, {Robert B.}",

year = "2012",

month = oct,

day = "22",

doi = "10.1186/1748-717X-7-174",

language = "English (US)",

volume = "7",

journal = "Radiation Oncology",

issn = "1748-717X",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - The clinical case for proton beam therapy

AU - Foote, Robert L.

AU - Stafford, Scott L.

AU - Petersen, Ivy A.

AU - Pulido, Jose S.

AU - Clarke, Michelle J.

AU - Schild, Steven E.

AU - Garces, Yolanda I.

AU - Olivier, Kenneth R.

AU - Miller, Robert C.

AU - Haddock, Michael G.

AU - Yan, Elizabeth

AU - Laack, Nadia N.

AU - Arndt, Carola A.S.

AU - Buskirk, Steven J.

AU - Miller, Vickie L.

AU - Brent, Christopher R.

AU - Kruse, Jon J.

AU - Ezzell, Gary A.

AU - Herman, Michael G.

AU - Gunderson, Leonard L.

AU - Erlichman, Charles

AU - Diasio, Robert B.

PY - 2012/10/22

Y1 - 2012/10/22

N2 - Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tumor control and survival through dose escalation. It also has potential for reducing harm to normal organs through dose reduction. However, proton beam therapy is more costly than conventional x-ray therapy. This increased cost may be offset by improved function, improved quality of life, and reduced costs related to treating the late effects of therapy. Clinical research opportunities are abundant to determine which patients will gain the most benefit from proton beam therapy. We review the clinical case for proton beam therapy.Proton beam therapy is a technically advanced and promising form of radiation therapy.

AB - Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tumor control and survival through dose escalation. It also has potential for reducing harm to normal organs through dose reduction. However, proton beam therapy is more costly than conventional x-ray therapy. This increased cost may be offset by improved function, improved quality of life, and reduced costs related to treating the late effects of therapy. Clinical research opportunities are abundant to determine which patients will gain the most benefit from proton beam therapy. We review the clinical case for proton beam therapy.Proton beam therapy is a technically advanced and promising form of radiation therapy.

KW - Clinical review

KW - Neoplasms

KW - Proton beam therapy

KW - X-ray therapy

UR - http://www.scopus.com/inward/record.url?scp=84867660663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867660663&partnerID=8YFLogxK

U2 - 10.1186/1748-717X-7-174

DO - 10.1186/1748-717X-7-174

M3 - Review article

C2 - 23083010

AN - SCOPUS:84867660663

SN - 1748-717X

VL - 7

JO - Radiation Oncology

JF - Radiation Oncology

IS - 1

M1 - 174

ER -

The clinical case for proton beam therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this